C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/42 (2006.01) A61K 31/4166 (2006.01) A61K 31/4178 (2006.01) A61K 31/5377 (2006.01) C07D 403/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2612398
Compounds having the structure or their salts are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. The compounds can be formulated together with pharmaceutically acceptable diluents or carriers or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.
L'invention porte sur des composés de structure suivante et sur leurs sels, utilisés pour traiter ou réduire la probabilité d'acquérir des maladies dépendantes des androgènes telles que: le cancer de la prostate, l'hyperplasie bénigne de la prostate, le syndrome des ovaires polykystiques, l'acné, l'hirsutisme, la séborrhée, l'alopécie androgène et la calvitie masculine. Lesdits composés peuvent être associés à des diluants ou excipients pharmacocompatibles, ou autrement produits en tant que formes posologiques. On peut également prévoir leur combinaison avec d'autres principes pharmaceutiques actifs.
Breton Rock
Labrie Fernand
Maltais Rene
Singh Shankar Mohan
Endorecherche Inc.
Marks & Clerk
LandOfFree
Helix 12 directed non-steroidal antiandrogens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Helix 12 directed non-steroidal antiandrogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Helix 12 directed non-steroidal antiandrogens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1721034